-transparent.png){kind=logo}
The pupil dilation response to tropicamide has been proposed as a simple test for demonstrating the central cholinergic deficit present in Alzheimer's disease (AD). We examined this response in 20 patients with clinically diagnosed mild probable AD and in 20 unrelated, cognitively intact, age-matched controls. A marked increase in pupil diameter was observed within 30 minutes in both groups. Differences between the groups did not attain statistical significance. The ability of the proposed test to discriminate between AD patients and healthy controls may be influenced by experimental procedures and by the ethnic background of the subjects under study. At present the pupil dilation response to tropicamide cannot be considered a useful diagnostic aid.
A Kurz, and
R Marquard, and
S Fremke, and
K P Leipert
January 1996,
Revista de neurologia,
A Kurz, and
R Marquard, and
S Fremke, and
K P Leipert
July 1997,
Archives of neurology,
A Kurz, and
R Marquard, and
S Fremke, and
K P Leipert
August 1996,
Acta neurologica Scandinavica,
A Kurz, and
R Marquard, and
S Fremke, and
K P Leipert
February 1997,
Archives of neurology,
A Kurz, and
R Marquard, and
S Fremke, and
K P Leipert
July 1985,
American journal of optometry and physiological optics,
A Kurz, and
R Marquard, and
S Fremke, and
K P Leipert
February 2006,
Journal of cataract and refractive surgery,
A Kurz, and
R Marquard, and
S Fremke, and
K P Leipert
December 2005,
Journal of cataract and refractive surgery,
A Kurz, and
R Marquard, and
S Fremke, and
K P Leipert
October 2003,
Neurobiology of aging,
A Kurz, and
R Marquard, and
S Fremke, and
K P Leipert
November 2006,
Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
A Kurz, and
R Marquard, and
S Fremke, and
K P Leipert
March 1996,
British journal of clinical pharmacology,
